Compare CLNN & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLNN | LPAA |
|---|---|---|
| Founded | 2012 | 2024 |
| Country | United States | United States |
| Employees | 79 | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.1M | 80.9M |
| IPO Year | N/A | N/A |
| Metric | CLNN | LPAA |
|---|---|---|
| Price | $5.27 | $10.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $33.75 | N/A |
| AVG Volume (30 Days) | 52.0K | ★ 54.9K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.64 | N/A |
| Revenue Next Year | $19,516.77 | N/A |
| P/E Ratio | ★ N/A | $31.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.50 | $10.39 |
| 52 Week High | $13.50 | $11.67 |
| Indicator | CLNN | LPAA |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 44.28 |
| Support Level | $4.53 | $10.47 |
| Resistance Level | $6.61 | $11.19 |
| Average True Range (ATR) | 0.31 | 0.11 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 51.20 | 0.00 |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Launch One Acquisition Corp is a blank check company.